Application of soybean peptide combined lactic acid bacteria in preparation of products for inhibiting intestinal pathogens

• Main Authors: LIU XINQI, WANG JINGYI, WEN YANCHAO, ZHANG YINXIAO, ZHANG CHI, LI HE
• Format: Patent
• Language: Chinese; English
• Published: 25.07.2023
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS THEREOF; CULTURE MEDIA; ENZYMOLOGY; FOODS OR FOODSTUFFS; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL; PROCESSES USING MICROORGANISMS; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES; VINEGAR; WINE

The invention provides application of soybean peptide combined lactic acid bacteria in preparation of products for inhibiting intestinal pathogens, and belongs to the technical field of intestinal regulation. According to the soybean peptide, the living cell number and acid yield of lactobacillus reuteri LR08 are increased, the capacity of competing for a nitrogen source with escherichia coli ESS is improved, and the soybean peptide cooperates with the lactobacillus reuteri LR08 to inhibit the activity of the escherichia coli ESS, so that potential problems related to intestinal flora disorder are solved, and the technical effects of adjusting intestinal flora and maintaining intestinal health are achieved. 本发明提供了一种大豆肽联合乳酸菌在制备抑制肠道病原菌产品中的应用，属于肠道调节技术领域。本发明所述大豆肽通过促进罗伊氏乳杆菌LR08活细胞数和产酸量的提升，与大肠杆菌ESS竞争氮源能力的提升，并协同其抑制大肠杆菌ESS的活性，以解决肠道菌群紊乱相关的潜在问题，达到调节肠道菌群、维护肠道健康的技术效果。